{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:37Z","timestamp":1793694637967,"version":"4.5.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Keratins<\/jats:italic>\n                    (\n                    <jats:italic>KRTs<\/jats:italic>\n                    ), the intermediate filament-forming proteins of epithelial cells, are extensively used as diagnostic biomarkers in cancers and associated with tumorigenesis and metastasis in multiple cancers. However, the diverse expression patterns and prognostic values of\n                    <jats:italic>KRTs<\/jats:italic>\n                    in melanoma have yet to be elucidated. In the current study, we examined the transcriptional and clinical data of\n                    <jats:italic>KRTs<\/jats:italic>\n                    in patients with melanoma from GEO, TCGA, ONCOMINE, GEPIA, cBioPortal, TIMER and TISIDB databases. We found that the mRNA levels of\n                    <jats:italic>KRT1\/2\/5\/6\/8\/10\/14\/15\/16\/17<\/jats:italic>\n                    were significantly differential expressed between primary melanoma and metastatic melanoma. The expression levels of\n                    <jats:italic>KRT1\/2\/5\/6\/10\/14\/15\/16\/17<\/jats:italic>\n                    were correlated with advanced tumor stage. Survival analysis revealed that the high transcription levels of\n                    <jats:italic>KRT1\/5\/6\/14\/15\/16\/17<\/jats:italic>\n                    were associated with low overall survival in melanoma patients. GSEA analysis indicated that the most involved hallmarks pathways were\n                    <jats:italic>P53<\/jats:italic>\n                    pathway,\n                    <jats:italic>KRAS<\/jats:italic>\n                    signaling, estrogen response early and estrogen response late. Furthermore, we found some correlations among the expression of\n                    <jats:italic>KRTs<\/jats:italic>\n                    and the infiltration of immune cells. Our study may provide novel insights for the selection of prognostic biomarkers for melanoma.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-80336-8","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T06:26:43Z","timestamp":1610519203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Transcript levels of keratin 1\/5\/6\/14\/15\/16\/17 as potential prognostic indicators in melanoma patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Wei","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"80336_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/s0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf, D. et al. Melanoma. Lancet 392, 971\u2013984. https:\/\/doi.org\/10.1016\/s0140-6736(18)31559-9 (2018).","journal-title":"Lancet"},{"key":"80336_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","volume":"15","author":"H Wallace","year":"1984","unstructured":"Wallace, H. et al. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol. 15, 1147\u20131165 (1984).","journal-title":"Hum. Pathol."},{"key":"80336_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaad.2008.10.065","volume":"60","author":"A Gadeliya Goodson","year":"2009","unstructured":"Gadeliya Goodson, A. & Grossman, D. Strategies for early melanoma detection: Approaches to the patient with nevi. J. Am. Acad. Dermatol. 60, 719\u2013735. https:\/\/doi.org\/10.1016\/j.jaad.2008.10.065 (2009).","journal-title":"J. Am. Acad. Dermatol."},{"key":"80336_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrc3218","volume":"12","author":"KT Flaherty","year":"2012","unstructured":"Flaherty, K. T., Hodi, F. S. & Fisher, D. E. From genes to drugs: Targeted strategies for melanoma. Nat. Rev. Cancer 12, 349\u2013361. https:\/\/doi.org\/10.1038\/nrc3218 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"80336_CR5","doi-asserted-by":"publisher","first-page":"e1468956","DOI":"10.1080\/2162402x.2018.1468956","volume":"7","author":"DL Bajor","year":"2018","unstructured":"Bajor, D. L. et al. Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma. Oncoimmunology 7, e1468956. https:\/\/doi.org\/10.1080\/2162402x.2018.1468956 (2018).","journal-title":"Oncoimmunology"},{"key":"80336_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050497","author":"P Sharma","year":"2019","unstructured":"Sharma, P., Alsharif, S., Fallatah, A. & Chung, B. M. Intermediate filaments as effectors of cancer development and metastasis: A focus on keratins, vimentin, and nestin. Cells https:\/\/doi.org\/10.3390\/cells8050497 (2019).","journal-title":"Cells"},{"key":"80336_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/onc.2010.456","volume":"30","author":"V Karantza","year":"2010","unstructured":"Karantza, V. Keratins in health and cancer: More than mere epithelial cell markers. Oncogene 30, 127\u2013138. https:\/\/doi.org\/10.1038\/onc.2010.456 (2010).","journal-title":"Oncogene"},{"key":"80336_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02665-x","author":"M Fujioka","year":"2020","unstructured":"Fujioka, M. et al. Dimethylarsinic acid (DMA) enhanced lung carcinogenesis via histone H3K9 modification in a transplacental mouse model. Arch. Toxicol. https:\/\/doi.org\/10.1007\/s00204-020-02665-x (2020).","journal-title":"Arch. Toxicol."},{"key":"80336_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1078-0432.CCR-11-2100","volume":"18","author":"SA Joosse","year":"2012","unstructured":"Joosse, S. A. et al. Changes in keratin expression during metastatic progression of breast cancer: Impact on the detection of circulating tumor cells. Clin. Cancer Res. 18, 993\u20131003. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2100 (2012).","journal-title":"Clin. Cancer Res."},{"key":"80336_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/carcin\/bgw063","volume":"37","author":"JO Misiorek","year":"2016","unstructured":"Misiorek, J. O. et al. Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway. Carcinogenesis 37, 777\u2013786. https:\/\/doi.org\/10.1093\/carcin\/bgw063 (2016).","journal-title":"Carcinogenesis"},{"key":"80336_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ygeno.2003.10.007","volume":"83","author":"Z Wang","year":"2004","unstructured":"Wang, Z., Dooley, T. P., Curto, E. V., Davis, R. L. & VandeBerg, J. L. Cross-species application of cDNA microarrays to profile gene expression using UV-induced melanoma in Monodelphis domestica as the model system. Genomics 83, 588\u2013599. https:\/\/doi.org\/10.1016\/j.ygeno.2003.10.007 (2004).","journal-title":"Genomics"},{"key":"80336_CR12","doi-asserted-by":"publisher","first-page":"10770","DOI":"10.1371\/journal.pone.0010770","volume":"5","author":"O Kabbarah","year":"2010","unstructured":"Kabbarah, O. et al. Human melanoma samples comparing nevi and primary and metastatic melanoma. PLoS ONE 5, 10770 (2010).","journal-title":"PLoS ONE"},{"key":"80336_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R. et al. ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6, 1\u20136. https:\/\/doi.org\/10.1016\/s1476-5586(04)80047-2 (2004).","journal-title":"Neoplasia"},{"key":"80336_CR14","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102. https:\/\/doi.org\/10.1093\/nar\/gkx247 (2017).","journal-title":"Nucleic Acids Res."},{"key":"80336_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/path.2440","volume":"216","author":"F Ponten","year":"2008","unstructured":"Ponten, F., Jirstrom, K. & Uhlen, M. The human protein atlas\u2014A tool for pathology. J Pathol 216, 387\u2013393. https:\/\/doi.org\/10.1002\/path.2440 (2008).","journal-title":"J Pathol"},{"key":"80336_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.Cd-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data: Figure 1. Cancer Discov. 2, 401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.Cd-12-0095 (2012).","journal-title":"Cancer Discov."},{"key":"80336_CR17","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini, A. et al. STRING v9.1: Protein\u2013protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-815. https:\/\/doi.org\/10.1093\/nar\/gks1094 (2013).","journal-title":"Nucleic Acids Res."},{"key":"80336_CR18","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang, D. W. et al. The DAVID gene functional classification tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8, R183. https:\/\/doi.org\/10.1186\/gb-2007-8-9-r183 (2007).","journal-title":"Genome Biol."},{"key":"80336_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329. https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nat. Genet."},{"key":"80336_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/bioinformatics\/btt019","volume":"29","author":"G Bindea","year":"2013","unstructured":"Bindea, G., Galon, J. & Mlecnik, B. CluePedia Cytoscape plugin: Pathway insights using integrated experimental and in silico data. Bioinformatics 29, 661\u2013663. https:\/\/doi.org\/10.1093\/bioinformatics\/btt019 (2013).","journal-title":"Bioinformatics"},{"key":"80336_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"80336_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8794-1-13","volume":"1","author":"AI Riker","year":"2008","unstructured":"Riker, A. I. et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics 1, 13. https:\/\/doi.org\/10.1186\/1755-8794-1-13 (2008).","journal-title":"BMC Med. Genomics"},{"key":"80336_CR23","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","volume":"11","author":"D Talantov","year":"2005","unstructured":"Talantov, D. et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin. Cancer Res. 11, 7234\u20137242. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0683 (2005).","journal-title":"Clin. Cancer Res."},{"key":"80336_CR24","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","volume":"16","author":"AM Goodman","year":"2017","unstructured":"Goodman, A. M. et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol. Cancer Ther. 16, 2598\u20132608. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0386 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"80336_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2559.2002.01387.x","volume":"40","author":"PG Chu","year":"2002","unstructured":"Chu, P. G. & Weiss, L. M. Keratin expression in human tissues and neoplasms. Histopathology 40, 403\u2013439. https:\/\/doi.org\/10.1046\/j.1365-2559.2002.01387.x (2002).","journal-title":"Histopathology"},{"key":"80336_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(82)90400-7","volume":"31","author":"R Moll","year":"1982","unstructured":"Moll, R., Franke, W. W., Schiller, D. L., Geiger, B. & Krepler, R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31, 11\u201324. https:\/\/doi.org\/10.1016\/0092-8674(82)90400-7 (1982).","journal-title":"Cell"},{"key":"80336_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/modpathol.3800456","volume":"18","author":"M Laakso","year":"2005","unstructured":"Laakso, M., Loman, N., Borg, A. & Isola, J. Cytokeratin 5\/14-positive breast cancer: True basal phenotype confined to BRCA1 tumors. Mod. Pathol. 18, 1321\u20131328. https:\/\/doi.org\/10.1038\/modpathol.3800456 (2005).","journal-title":"Mod. Pathol."},{"key":"80336_CR28","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0002-9440(10)64476-8","volume":"161","author":"M van de Rijn","year":"2002","unstructured":"van de Rijn, M. et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am. J. Pathol. 161, 1991\u20131996 (2002).","journal-title":"Am. J. Pathol."},{"key":"80336_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0014-5793(97)00290-1","volume":"407","author":"Y Katagata","year":"1997","unstructured":"Katagata, Y. & Kondo, S. Keratin expression and its significance in five cultured melanoma cell lines derived from primary, recurrent and metastasized melanomas. FEBS Lett. 407, 25\u201331. https:\/\/doi.org\/10.1016\/s0014-5793(97)00290-1 (1997).","journal-title":"FEBS Lett."},{"key":"80336_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1126\/science.279.5350.514","volume":"279","author":"E Fuchs","year":"1998","unstructured":"Fuchs, E. & Cleveland, D. W. A structural scaffolding of intermediate filaments in health and disease. Science 279, 514\u2013519. https:\/\/doi.org\/10.1126\/science.279.5350.514 (1998).","journal-title":"Science"},{"key":"80336_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.6b00652","volume":"14","author":"S Rania","year":"2017","unstructured":"Rania, S., Etayash, H., Bahadorani, K., Lavasanifar, A. & Kamaljit, K. Breast cancer targeting peptide binds keratin 1: A new molecular marker for targeted drug delivery to breast cancer. Mol. Pharm. 14, 593\u2013604. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00652 (2017).","journal-title":"Mol. Pharm."},{"key":"80336_CR32","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1038\/jid.2014.197","volume":"134","author":"H Fischer","year":"2014","unstructured":"Fischer, H. et al. Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation. J. Invest. Dermatol. 134, 2579\u20132588. https:\/\/doi.org\/10.1038\/jid.2014.197 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"80336_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.acthis.2016.05.004","volume":"118","author":"YC Cui","year":"2016","unstructured":"Cui, Y. C. et al. The expression of KRT2 and its effect on melanogenesis in alpaca skins. Acta Histochem. 118, 505\u2013512. https:\/\/doi.org\/10.1016\/j.acthis.2016.05.004 (2016).","journal-title":"Acta Histochem."},{"key":"80336_CR34","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1468-3083.2011.04115.x","volume":"26","author":"L Guo","year":"2012","unstructured":"Guo, L. et al. A novel heterozygous nonsense mutation of keratin 5 in a Chinese family with Dowling-Degos disease. J. Eur. Acad. Dermatol. Venereol. 26, 908\u2013910. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04115.x (2012).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"80336_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1479-5876-7-86","volume":"7","author":"G Palmieri","year":"2009","unstructured":"Palmieri, G. et al. Main roads to melanoma. J. Transl. Med. 7, 86. https:\/\/doi.org\/10.1186\/1479-5876-7-86 (2009).","journal-title":"J. Transl. Med."},{"key":"80336_CR36","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1083\/jcb.201712130","volume":"217","author":"FR Wang","year":"2018","unstructured":"Wang, F. R., Chen, S., Liu, H. B., Parent, C. A. & Coulombe, P. A. Keratin 6 regulates collective keratinocyte migration by altering cell\u2013cell and cell\u2013matrix adhesion. J. Cell Biol. 217, 4314\u20134330. https:\/\/doi.org\/10.1083\/jcb.201712130 (2018).","journal-title":"J. Cell Biol."},{"key":"80336_CR37","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.3892\/mmr.2019.10055","volume":"19","author":"CJ Chen","year":"2019","unstructured":"Chen, C. J. & Shan, H. G. Keratin 6A gene silencing suppresses cell invasion and metastasis of nasopharyngeal carcinoma via the \u03b2-catenin cascade. Mol. Med. Rep. 19, 3477\u20133484. https:\/\/doi.org\/10.3892\/mmr.2019.10055 (2019).","journal-title":"Mol. Med. Rep."},{"key":"80336_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13258-019-00889-5","volume":"42","author":"HB Hu","year":"2020","unstructured":"Hu, H. B., Yang, X. P., Zhou, P. X., Yang, X. A. & Yin, B. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma. Genes Genom. 42, 179\u2013188. https:\/\/doi.org\/10.1007\/s13258-019-00889-5 (2020).","journal-title":"Genes Genom."},{"key":"80336_CR39","doi-asserted-by":"publisher","first-page":"D1403","DOI":"10.2741\/gonias","volume":"6","author":"SL Gonias","year":"2001","unstructured":"Gonias, S. L., Hembrough, T. A. & Sankovic, M. Cytokeratin 8 functions as a major plasminogen receptor in select epithelial and carcinoma cells. Front. Biosci. 6, D1403-1411. https:\/\/doi.org\/10.2741\/gonias (2001).","journal-title":"Front. Biosci."},{"key":"80336_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/febs.14401","volume":"285","author":"R Tiwari","year":"2018","unstructured":"Tiwari, R. et al. Depletion of keratin 8\/18 modulates oncogenic potential by governing multiple signaling pathways. FEBS J. 285, 1251\u20131276. https:\/\/doi.org\/10.1111\/febs.14401 (2018).","journal-title":"FEBS J."},{"key":"80336_CR41","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.oooo.2015.11.016","volume":"121","author":"RA Safadi","year":"2016","unstructured":"Safadi, R. A., Bader, D. H., Abdullah, N. I. & Sughayer, M. A. Immunohistochemical expression of keratins 6, 7, 8, 14, 16, 18, 19, and MNF-116 pancytokeratin in primary and metastatic melanoma of the head and neck. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 121, 510\u2013519. https:\/\/doi.org\/10.1016\/j.oooo.2015.11.016 (2016).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"80336_CR42","first-page":"63","volume":"148","author":"YW Chu","year":"1996","unstructured":"Chu, Y. W., Seftor, E. A., Romer, L. H. & Hendrix, M. J. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am. J. Pathol. 148, 63\u201369 (1996).","journal-title":"Am. J. Pathol."},{"key":"80336_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1541-7786.Mcr-04-0117","volume":"3","author":"H Buhler","year":"2005","unstructured":"Buhler, H. & Schaller, G. Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo. Mol. Cancer Res. 3, 365\u2013371. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-04-0117 (2005).","journal-title":"Mol. Cancer Res."},{"key":"80336_CR44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1242\/jcs.110.8.965","volume":"110","author":"R Pankov","year":"1997","unstructured":"Pankov, R., Simcha, I., Z\u00f6ller, M., Oshima, R. G. & Ben-Ze\u2019ev, A. Contrasting effects of K8 and K18 on stabilizing K19 expression, cell motility and tumorigenicity in the BSp73 adenocarcinoma. J. Cell Sci. 110, 965\u2013974 (1997).","journal-title":"J. Cell Sci."},{"key":"80336_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.humpath.2010.09.004","volume":"42","author":"GG Rezze","year":"2011","unstructured":"Rezze, G. G., Fregnani, J. H., Duprat, J. & Landman, G. Cell adhesion and communication proteins are differentially expressed in melanoma progression model. Hum. Pathol. 42, 409\u2013418. https:\/\/doi.org\/10.1016\/j.humpath.2010.09.004 (2011).","journal-title":"Hum. Pathol."},{"key":"80336_CR46","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1111\/jdv.13345","volume":"30","author":"PJ Chen","year":"2016","unstructured":"Chen, P. J. et al. S159P mutation of keratin 10 gene causes severe form of epidermolytic hyperkeratosis. J. Eur. Acad. Dermatol. Venereol. 30, e102\u2013e104. https:\/\/doi.org\/10.1111\/jdv.13345 (2016).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"80336_CR47","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/jid.2015.284","volume":"135","author":"H Mirza","year":"2015","unstructured":"Mirza, H. et al. Mutations affecting keratin 10 surface-exposed residues highlight the structural basis of phenotypic variation in epidermolytic ichthyosis. J. Invest. Dermatol. 135, 3041\u20133050. https:\/\/doi.org\/10.1038\/jid.2015.284 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"80336_CR48","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1002\/ajmg.a.38403","volume":"173","author":"A Kalinska-Bienias","year":"2017","unstructured":"Kalinska-Bienias, A. et al. Coexistence of mutations in keratin 10 (KRT10) and the mitochondrial genome in a patient with ichthyosis with confetti and Leber\u2019s hereditary optic neuropathy. Am. J. Med. Genet. A 173, 3093\u20133097. https:\/\/doi.org\/10.1002\/ajmg.a.38403 (2017).","journal-title":"Am. J. Med. Genet. A"},{"key":"80336_CR49","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1242\/jcs.03298","volume":"119","author":"JL Chen","year":"2006","unstructured":"Chen, J. L. et al. An unexpected role for keratin 10 end domains in susceptibility to skin cancer. J. Cell Sci. 119, 5067\u20135076. https:\/\/doi.org\/10.1242\/jcs.03298 (2006).","journal-title":"J. Cell Sci."},{"key":"80336_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-14-1","volume":"14","author":"O Kodet","year":"2015","unstructured":"Kodet, O. et al. Melanoma cells influence the differentiation pattern of human epidermal keratinocytes. Mol. Cancer 14, 1. https:\/\/doi.org\/10.1186\/1476-4598-14-1 (2015).","journal-title":"Mol. Cancer"},{"key":"80336_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091228","author":"M Bilandzic","year":"2019","unstructured":"Bilandzic, M. et al. Keratin-14 (KRT14) positive leader cells mediate mesothelial clearance and invasion by ovarian cancer cells. Cancers https:\/\/doi.org\/10.3390\/cancers11091228 (2019).","journal-title":"Cancers"},{"key":"80336_CR52","doi-asserted-by":"publisher","first-page":"11914","DOI":"10.1038\/ncomms11914","volume":"7","author":"G Papafotiou","year":"2016","unstructured":"Papafotiou, G. et al. KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis. Nat. Commun. 7, 11914. https:\/\/doi.org\/10.1038\/ncomms11914 (2016).","journal-title":"Nat. Commun."},{"key":"80336_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1523-1747.1999.00535.x","volume":"112","author":"A Waseem","year":"1999","unstructured":"Waseem, A. et al. Keratin 15 expression in stratified epithelia: Downregulation in activated keratinocytes. J. Invest. Dermatol. 112, 362\u2013369. https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00535.x (1999).","journal-title":"J. Invest. Dermatol."},{"key":"80336_CR54","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/ijc.23660","volume":"123","author":"D Cimino","year":"2008","unstructured":"Cimino, D. et al. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues. Int. J. Cancer 123, 1327\u20131338. https:\/\/doi.org\/10.1002\/ijc.23660 (2008).","journal-title":"Int. J. Cancer"},{"key":"80336_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-011-1555-6","volume":"132","author":"LY Chong","year":"2012","unstructured":"Chong, L. Y. et al. Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: Novel markers in biological classification. Breast Cancer Res. Treat. 132, 143\u2013151. https:\/\/doi.org\/10.1007\/s10549-011-1555-6 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"80336_CR56","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.7150\/ijms.5747","volume":"10","author":"L Boyero","year":"2013","unstructured":"Boyero, L. et al. Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer. Int. J. Med. Sci. 10, 1166\u20131173. https:\/\/doi.org\/10.7150\/ijms.5747 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"80336_CR57","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.0022-202X.2004.22207.x","volume":"122","author":"L Ghali","year":"2004","unstructured":"Ghali, L. et al. Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulfate proteoglycan core protein. J. Invest. Dermatol. 122, 433\u2013442. https:\/\/doi.org\/10.1046\/j.0022-202X.2004.22207.x (2004).","journal-title":"J. Invest. Dermatol."},{"key":"80336_CR58","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.7150\/ijbs.34076","volume":"15","author":"YH Liu","year":"2019","unstructured":"Liu, Y. H. et al. TFAP2A induced KRT16 as an oncogene in lung adenocarcinoma via EMT. Int. J. Biol. Sci. 15, 1419\u20131428. https:\/\/doi.org\/10.7150\/ijbs.34076 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"80336_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13046-019-1091-5","volume":"38","author":"WC Huang","year":"2019","unstructured":"Huang, W. C. et al. A novel miR-365-3p\/EHF\/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing \u03b25-integrin\/c-met signaling pathway. J. Exp. Clin. Cancer Res. 38, 89. https:\/\/doi.org\/10.1186\/s13046-019-1091-5 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"80336_CR60","doi-asserted-by":"publisher","first-page":"e0190447","DOI":"10.1371\/journal.pone.0190447","volume":"13","author":"LX Wang","year":"2018","unstructured":"Wang, L. X., Li, Y. & Chen, G. Z. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma. PLoS ONE 13, e0190447. https:\/\/doi.org\/10.1371\/journal.pone.0190447 (2018).","journal-title":"PLoS ONE"},{"key":"80336_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17330-0","author":"R Metri","year":"2017","unstructured":"Metri, R. et al. Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-17330-0 (2017).","journal-title":"Sci. Rep."},{"key":"80336_CR62","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s10120-017-0712-y","volume":"20","author":"M Chivu-Economescu","year":"2017","unstructured":"Chivu-Economescu, M. et al. Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells. Gastric Cancer 20, 948\u2013959. https:\/\/doi.org\/10.1007\/s10120-017-0712-y (2017).","journal-title":"Gastric Cancer"},{"key":"80336_CR63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/path.5178","volume":"247","author":"L Yang","year":"2019","unstructured":"Yang, L., Zhang, S. & Wang, G. Keratin 17 in disease pathogenesis: From cancer to dermatoses. J. Pathol. 247, 158\u2013165. https:\/\/doi.org\/10.1002\/path.5178 (2019).","journal-title":"J. Pathol."},{"key":"80336_CR64","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1530\/joe-16-0324","volume":"231","author":"CP Kung","year":"2016","unstructured":"Kung, C. P. & Murphy, M. E. The role of the p53 tumor suppressor in metabolism and diabetes. J. Endocrinol. 231, R61\u2013R75. https:\/\/doi.org\/10.1530\/joe-16-0324 (2016).","journal-title":"J. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80336-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80336-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T21:10:05Z","timestamp":1670015405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80336-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80336"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80336-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"25 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1023"}}